Frank Y. Lin

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 800 citations

Medicine, Pharmacology, Pharmacotherapy +6

Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors

D. Williams Parsons, Angshumoy Roy, Yaping Yang et al. · JAMA Oncology · 2016 · 500 citations · Full text

Medicine, Oncology, Pediatrics +17

Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

Gil I. Wolfe, Henry J. Kaminski, Inmaculada Aban et al. · The Lancet Neurology · 2019 · 223 citations · Full text

Medicine, Endocrinology, Surgery +5

BCOR–CCNB3 fusions are frequent in undifferentiated sarcomas of male children

Tricia Peters, Vijetha Kumar, Sumanth Polikepahad et al. · Modern Pathology · 2014 · 158 citations · Full text

Medicine, Oncology, Pathology +13

Outcomes of BRAF V600E Pediatric Gliomas Treated With Targeted BRAF Inhibition

Liana Nobre, Michal Zápotocký, Vijay Ramaswamy et al. · JCO Precision Oncology · 2020 · 142 citations · Full text

Medicine, Oncology, Pediatrics +15